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Cinnamon-containing polycaprolactone (PCL) bandages were produced by pres-
surised gyration and their anti-fungal activities against Candida albicans were
investigated. It was found that by preparing and spinning polymer solutions of cin-
namon with PCL, fibres capable of inhibiting fungal growth could be produced, as
observed in disk diffusion tests for anti-fungal susceptibility. Fascinatingly, com-
pared with raw cinnamon powder, the novel cinnamon-loaded fibres had outstand-
ing long-term activity. The results presented here are very promising and may
indeed accelerate a new era of using completely natural materials in biomedical
applications, especially in wound healing.
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1 | INTRODUCTION
Even before the discovery of modern antibiotics, anti-
microbial agents, for example, spices, have existed in con-
sumable form. Several commonly eaten foods have the
uncultivated ability to inhibit microbial growth, which
remained unknown to the consumer. These spices are not
only abundant but also come at relatively little cost whilst
being completely natural and having a minor impact on the
environment. Cinnamon (Cinnamomum) is a spice acquired
from the inner dried bark of several species of trees indige-
nous to South Asia and China and belongs to the genus Cin-
namomum.1 Cinnamon is grown commercially and is used
in cosmetics, as a flavouring additive in a wide variety of
cuisines worldwide, and as an aromatic condiment. The his-
tory of cinnamon usage dates back thousands of years where
references to it are found in the Bible. The ancient Egyptians
even used the spice as embalming fluid for the wealthy
deceased.1 Arguably, two most prevalent types of cinnamon
exist, Cinnamomum verum (Ceylon) and Cinnamomum
cassia. Ceylon cinnamon is considered amongst most to be
the “true cinnamon” whilst cassia cinnamon is most com-
monly found in international commerce and thus holds a
lower trading value.2 The principal chemical component of
cinnamon, cinnamaldehyde, gives the spice its unique aroma
and flavour; cassia variants contain more cinnamaldehyde in
their essential oil.3 Historically, cinnamon has been long used
as a traditional medicine in the treatment of many conditions,
such as bronchitis, rheumatism, and neuralgia.4 Furthermore,
many modern scientific articles report on the ability of cinna-
mon to be antidiabetic, antioxidant, anti-inflammatory, anti-
fungal, anti-HIV, improve heart function, pro-wound healing,
and anti-cancer.5–10 It has been reported that cinnamaldehyde
holds remarkable anti-microbial activity.11–14
Candida albicans is found in abundance in the human
gut flora of around 50% of all healthy adults and is an oppor-
tunistic pathogenic yeast.15,16 C. albicans is known to cause
human infections such as candidiasis, which occurs as a
result of its overgrowth and is a contributing factor in tooth
decay.17,18 Furthermore, C. albicans is the most common
fungal species found to form as a biofilm on medical
implants and is the cause of many implant failures.19 Cost of
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treatment for patients only increases because of the rise of
hospital-acquired infections.20 The usage of bandages and
gauzes still remains a highly prevalent foundation of wound
care in many countries.21,22 The anti-fungal effect of
cinnamon-blended polymeric fibres on C. albicans is studied
in this article. There is an abundance of work completed in
anti-microbial materials, but here we investigate a
completely natural solution.23,24
2 | MATERIALS AND METHODS
2.1 | Fibre preparation
Solvent extraction via chloroform (CAS Number: 67–66-3,
Sigma Aldrich, UK) was carried out in order to formulate vary-
ing concentrations of cinnamon in solution. Three cinnamon
(cassia) extractions (C1, C2, and C3) of differing concentra-
tions where prepared from ground cinnamon powder
(JustIngredients, UK). The extraction process involved mix-
ing 6, 9, and 12 g into 24 mL of chloroform; the solution
was vortexed, excess cinnamon that was not dissolved into
the solvent was separated by addition of 10 mL distilled
water and centrifugation at 2000 rpm for 15 minutes. Four
concentrations of fibres were tested in this investigation: vir-
gin PCL fibres with no cinnamon, C1, C2, and C3 fibres
with 6, 9, and 12 g cinnamon per 24 mL of chloroform,
respectively. PCL (Mn 80 000, Sigma Aldrich, UK) was
added to the cinnamon extract solutions to make a concen-
tration of 15% (w/v) and magnetically stirred overnight to
produce a polymer solution. The solutions were spun with a
laboratory-pressurised gyration set up that consists of a small
(60 × 35 mm2) aluminium cylindrical vessel with multiple,
narrow (0.5 mm) perforations that is connected to a gas inlet
and a high-speed motor to produce fibre meshes.25 A 4 mL
volume of the polymer solution was spun with pressurised
gyration for 20 seconds in order to obtain a fibrous square
bandage under ambient conditions (24C and 42% relative
humidity). Figure 1 depicts the fibre-forming setup that has
completed a single spin of 4 mL PCL polymer solution.
FIGURE 1 Picture of pressurised gyration setup, showing a high yield of
polycaprolactone fibres resembling bandages, produced with 4 mL of
polymer solution
Key Messages
• raw materials such as cinnamon possess potent anti-fungal
activity, which can be used in wound care to create anti-
microbial bandages using only natural materials
• in this study, extracted cinnamon was used to create polymeric
fibrons bandages using a novel method, these bandages were
tested for their anti-fungal effect using three different concen-
trations of extracts
• it was found that the raw material had good anti-fungal activ-
ity, but by increasing the concentration of the extract, there
was an increase in anti-fungal power
• these results show that there is a facile method for producing
bandages using natural materials, which also avoids the envi-
ronmentally unfriendly processes of purification, the resulting
bandages are also highly anti-fungal, longer-lasting, and can
help to prevent infections in a health care environment
FIGURE 2 Pictures following 48 hours of incubation showing plates
containing; A, ground cinnamon powder, B, virgin polycaprolactone fibres,
showing lack of an inhibition area, C, C1 cinnamon-extracted fibres, D, C2
cinnamon-extracted fibres, E, C3 cinnamon-extracted fibres and in each
case, 100 mg of sample was investigated. For each plate, the inhibition area
value is given
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2.2 | Anti-fungal testing
A total of 100 mg of cinnamon-containing fibres (C1, C2,
and C3 samples) were tested at different concentrations in
10 mL of Mueller-Hinton agar (Sigma Aldrich, UK). A vol-
ume of 250 μL of C. albicans (population 4-5 × 106) was
distributed within the standard Petri dish. The fibres were
placed in the centre of the Petri dish in order to determine
any inhibition zones between the fungus and the samples.
The agar plates were incubated at 37C. As a negative con-
trol, the fibres containing PCL only were also used and inhi-
bition zones analysed. As a positive control, raw material of
cinnamon in powder form was tested as described previ-
ously. Images of the agar plates were taken following
48 hours from incubation, inhibition zones were calculated
as areas using Image J software. Scanning electron micros-
copy (Hitachi S-3400n, Tokyo, Japan) was used to analyse
the morphology of the fibres. Unless otherwise labelled, an
accelerating voltage of 5 kV was used to image the samples
which were gold sputter coated for 180s (Q150R ES Quo-
rum Technologies Ltd., Laughton, England).
3 | RESULTS
The anti-fungal capability of cinnamon was tested against
C. albicans where inhibition areas were used to determine
the effectiveness of each anti-fungal substance. Larger
FIGURE 4 Scanning electron microscopy images of pressure spun fibres at 0.1 MPa: A, virgin polycaprolactone (PCL) fibres, B, diameter distribution of the
virgin PCL fibres, C, PCL fibres with cinnamon-extract (C2), and D, diameter distribution of the cinnamon-loaded PCL fibres, in all cases, n = 100
FIGURE 3 Graph comparing inhibition areas of the different samples,
shown in Figure 2, n = 3
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inhibition zones were indicative of a greater ability for the
material to kill the fungal population, these have been com-
pared in the following results.
Inhibition zones for each of the samples were compared
for their effectiveness in preventing fungal growth. Compari-
sons were made on the average inhibition zone that was cal-
culated as an area for fair comparison. Larger inhibition
zones showed greater anti-fungal efficacy.
Fungus, like all other microbes, comes into contact with
the surface of materials. It is, therefore, important to study
the fibres to identify if any differences in fibre morphology
could have had an effect on the anti-fungal activity.
Inhibition zones clearly show anti-microbial effect, but
this could be because of a number of factors other than the
cinnamon extract. To eliminate doubt of the anti-fungal
ingredient, virgin PCL fibres containing no cinnamon extract
were seen under microscopy and compared with cinnamon-
extracted PCL fibres.
How long the anti-fungal effect lasts is also an important
consideration. Following 504 hours of initial incubation, the
samples were rephotographed to observe the longevity of the
anti-fungal influence.
4 | DISCUSSION
All of the samples cinnamon were anti-fungal as evident
from Figure 2 as it all shows inhibition areas devoid of fun-
gal growth. Figure 2A shows cinnamon powder demonstrat-
ing that, as expected, the raw ingredient does in fact have an
anti-fungal effect. Virgin PCL fibres without any cinnamon
extract are shown in Figure 2B and there is no zone of inhi-
bition as PCL itself is not anti-microbial, furthermore, it vali-
dates that the chloroform from the fibre-manufacturing
process has completely evaporated as otherwise this would
have led to an inhibition zone. It can also be seen that larger
inhibition zones surround the cinnamon-loaded fibres
(Figure 2C-E) as the concentration in the fibres increases
from 6 to 12 g/24 mL. As expected, using more cinnamon
powder in the extraction process leads to a higher concentra-
tion of cinnamaldehyde within the solution and subsequently
this is incorporated into the fibre bandages.
Virgin PCL fibres had an absence of any inhibition
zones as expected from the negative control as these ban-
dages were free from cinnamon extract (Figure 3). Raw cin-
namon powder expresses a larger inhibition area of
FIGURE 5 Fluorescence microscopy video stills of: A, C1 extracted cinnamon fibre showing a clear inhibition zone with no fungal growth, scanning
electron microscopy images of: B, C, candida growth over virgin PCL fibres, arrow marked in B, and D) high magnification image showing close-up of
Candida. albicans cell growth on virgin PCL fibre surface
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671 ± 49 mm2 and compared with the C1 cinnamon-loaded
fibres (475 ± 52 mm2). However, as the concentration
within the fibres increases from 6 to 12 g/24 mL, there is
enhanced potency in the anti-fungal activity as confirmed by
larger inhibition areas (722 ± 32 and 873 ± 39 mm2,
respectively). Extracts of cinnamon contain several active
compounds including cinnamaldehyde and tannins.26 Tan-
nins are known to inhibit growth of certain bacterial strains
such as Staphylococcus aureus.27 Cinnamaldehyde too is
anti-microbial because of its activity in inhibiting cell wall
synthesis of microbes.28 During the extraction process, the
powder and cellulose of the cinnamon were discarded leav-
ing only the chemical extract. The results here, therefore,
suggest that the anti-fungal effect may indeed be of chemical
origin. Having a lower minimum non-cytotoxic concentra-
tion than many other natural anti-microbial materials, it is
unlikely that the anti-fungal effect from cinnamon is because
of a toxic effect.29
The average fibre diameter of the virgin PCL fibres is
6.0 ± 2.6 μm, the diameter distribution of these fibres is
shown in Figure 4B. These thin fibres are able to carry the
active ingredients of cinnamon whilst acting as a physical
barrier to microbes such as fungi. These fibres contain
nano-pores that are the result of rapid solvent evaporation
and subsequent micro-droplet formation on the fibre sur-
face as detected in our previous work.30 These pores
increase the available surface area to volume ratio of the
bandages and also allow for the free movement of exudate
in and out of the bandage, which is a highly desired char-
acteristic for a wound dressing.31,32 Figure 4B shows
cinnamon-extract loaded PCL fibres (9 g), which have an
average fibre diameter of 2.3 ± 1.3 μm. Compared with
the virgin PCL fibres, the cinnamon-loaded fibres are thin-
ner and have a smaller diameter distribution (Figure 4D)
meaning that the fibre thicknesses are more uniform.
Lower-diameter fibres can be more beneficial in releasing
active ingredients because of the higher surface area to
volume ratio they afford.33
It is evident from Figure 5 that there is a clear inhibition
zone in between the extracted cinnamon-containing fibres
where C. albicans cells have failed to survive. The images
consist of three frames taken from a video clip (available in
FIGURE 6 Images taken 504 hours after initial incubation comparing: A, C1 extracted cinnamon-containing fibres (right-hand side) with raw cinnamon
powder (left-hand side) B, C2 extracted cinnamon-containing fibres C, C3 extracted cinnamon-containing fibres. All Petri dishes shown are 90 mm in
diameter
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Supporting Information), which pans an area between the
fibre and the fungi. Clearly, the extracted cinnamon-
containing fibres are successful in denying fungal
growth here.
Very interestingly, following 3 weeks of incubation, the
cinnamon powder solutions show a regrowth of fungal colo-
nies indicating that the anti-fungal effect of ground cinna-
mon powder is only temporary and given time, fungi are
able to grow into the previously formed inhibition zones
(Figure 6). All the extracted cinnamon fibres (6, 9 and 12 g)
still retain the exactly the same inhibition zones, demonstrat-
ing that the anti-fungal effect is not short-term and even after
3 weeks of 37C incubation, there is no regrowth of fungal
communities. One possible explanation for the regrowth of
fungi in the cinnamon powder is that the fungi are initially
repelled from the powder, but the surviving fungi are able to
grow in numbers and invade the powder that acts as their
food source for further growth. In any case, we have suc-
cessfully demonstrated here that we can obtain lasting anti-
fungal activity with cinnamon-loaded fibres. Compared with
raw cinnamon, there is no regrowth of fungi following
3 weeks.
5 | CONCLUSIONS
From the results presented in this work, it is obvious that the
gyrospun cinnamon-extract-containing bandages have a
strong anti-fungal effect. Compared with the negative con-
trol (Virgin PCL), there is a far greater inhibition area associ-
ated with these fibres. Cinnamon-loaded fibres had strong
anti-fungal activity that lasted in excess of 3 weeks, some-
thing that could not have been achieved if not in the fibre
form. This work opens up the possibility for crude unpuri-
fied extracts of natural materials to be used in wound care
and other anti-microbial filtering applications. The use of
such natural materials alleviates fear and concern of long-
term consequences and side effects as these materials have
been used by humans for many millennia. Spinning them
into bandage-like mats shows the manufacturing and health
care capability of such materials is very effective (as shown
here) when incorporated into a fibrous patch, environmen-
tally unfriendly purification can be avoided. Our work in
progress embraces other natural medicinal materials such as
garlic, cardamom, and aniseed.
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